KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.同业对比
KESTRA MEDICAL TECHNOLOGIES, LTD. 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KMTS本股 | $1.4B#8 | — | 6.5x#12 | 15.2x#14 | 59.0%#1 | -15.6%#11 | -141.6%#14 | -59.2%#13 | -59.5%#10 | 4#8 | 2.9%#6 | — |
| PLSE | $3.6B#1 | — | 36.3x#15 | 10311.2x#15 | — | -35.8%#13 | -21982.6%#15 | -73.1%#14 | — | — | 210.6%#1 | — |
| ATRC | $3.0B#2 | 281.3x#5 | 5.8x#11 | 5.6x#10 | 14.9%#7 | 74.4%#3 | -1.8%#6 | -2.2%#7 | -2.3%#4 | 7#1 | 68.6%#2 | — |
| UFPT | $2.1B#3 | 29.8x#3 | 4.6x#9 | 3.5x#7 | 19.5%#6 | 15.8%#8 | 15.3%#3 | 14.8%#3 | 13.4%#1 | 7#1 | 34.1%#4 | — |
| INSP | $2.1B#4 | 16.1x#1 | 2.5x#2 | 2.3x#4 | 13.6%#9 | 171.8%#2 | 5.6%#5 | 17.6%#2 | 7.1%#2 | 7#1 | -9.1%#9 | — |
| NVCR | $1.9B#5 | — | 5.8x#10 | 3.0x#6 | 8.3%#12 | 19.4%#6 | -23.5%#10 | -40.3%#11 | -35.0%#9 | 3#9 | — | — |
| LMAT | $1.8B#6 | 27.9x#2 | 4.3x#7 | 7.3x#11 | 13.5%#11 | 31.1%#5 | 27.2%#2 | 13.7%#4 | — | — | -12.6%#10 | 1.0%#2 |
| ATEC | $1.6B#7 | — | — | 2.1x#3 | 25.0%#4 | 11.6%#9 | -10.7%#7 | — | -18.5%#6 | 6#4 | -30.0%#11 | — |
| TNDM | $1.2B#9 | — | 9.2x#13 | 1.2x#2 | 7.9%#13 | -113.2%#15 | -18.5%#9 | -157.0%#15 | -26.3%#7 | 3#9 | 41.3%#3 | — |
| IART | $1.2B#10 | — | 1.1x#1 | 0.7x#1 | 1.5%#14 | -7389.9%#16 | -30.2%#11 | -49.5%#12 | -32.1%#8 | 6#4 | 2.0%#7 | — |
| AORT | $1.2B#11 | — | 2.6x#3 | 2.6x#5 | 13.6%#10 | 173.1%#1 | 7.6%#4 | 2.2%#5 | 3.0%#3 | 5#7 | -40.2%#12 | 0.3%#3 |
| PRCT | $1.1B#12 | — | 3.3x#4 | 3.6x#8 | 37.2%#3 | -4.5%#10 | -33.7%#12 | -0.0%#6 | -63.4%#11 | 2#11 | -47.8%#13 | — |
| IRMD | $1.1B#13 | 46.3x#4 | 10.4x#14 | 12.6x#13 | 14.4%#8 | 16.9%#7 | 31.2%#1 | 22.1%#1 | — | — | 17.4%#5 | 1.4%#1 |
| SGP | $979M#14 | — | 4.2x#6 | — | — | -36.7%#14 | — | -17.2%#9 | — | — | — | — |
| BBNX | $965M#15 | — | 3.8x#5 | 9.6x#12 | 53.9%#2 | -33.7%#12 | -71.5%#13 | -28.6%#10 | — | — | -7.1%#8 | — |
| SIBN | $810M#16 | — | 4.4x#8 | 4.0x#9 | 20.2%#5 | 38.8%#4 | -11.1%#8 | -10.4%#8 | -12.0%#5 | 6#4 | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议